Table 2.
Parameters | All patients n = 210 |
Group 1 BAV n = 70 |
Group 2 TAV n = 140 |
P-value |
---|---|---|---|---|
Serum glucose mg/dL | 126.1 ± 52.8 | 135.2 ± 69.3 | 121.6 ± 41.8 | 0.079 |
HbA1c (%) | 6.23 ± 1.2 | 6.54 ± 1.5 | 6.15 ± 0.9 | 0.084 |
Creatinine (mg/dL) | 1.01 ± 0.40 | 0.97 ± 0.30 | 1.03 ± 0.44 | 0.301 |
Total cholesterol (mg/dL) | 167.4 ± 43.6 | 159.8 ± 43.0 | 171.2 ± 43.7 | 0.074 |
Triglyceride (mg/dL) | 122.8 ± 69.8 | 118.7 ± 59.0 | 124.9 ± 74.8 | 0.543 |
LDL cholesterol (mg/dL) | 98.6 ± 35.3 | 94.7 ± 39.4 | 100.6 ± 33.0 | 0.249 |
HDL cholesterol (mg/dL) | 45.4 ± 13.2 | 42.1 ± 13.7 | 47.0 ± 12.7 | 0.012 |
Hemoglobin (mg/dL) | 11.7 ± 2.0 | 12.1 ± 1.7 | 11.4 ± 2.1 | 0.023 |
Neutrophil count, (× 103/L) | 4.80 ± 1.78 | 5.08 ± 1.82 | 4.65 ± 1.75 | 0.098 |
Lymphocyte count (× 103/L) | 1.59 ± 0.62 | 1.68 ± 0.61 | 1.55 ± 0.62 | 0.147 |
NLR | 3.41 ± 1.77 | 3.54 ± 2.09 | 3.34 ± 1.59 | 0.441 |
Monocyte count (× 103/L) | 0.59 ± 0.27 | 0.65 ± 0.26 | 0.55 ± 0.27 | 0.010 |
MHR | 44.6 ± 14.2 | 17.6 ± 10.1 | 12.4 ± 6.6 | <0.001 |
Platelet count (× 103/L) | 237.9 ± 81.3 | 243.4 ± 96.8 | 235.1 ± 72.6 | 0.488 |
MPV (fL) | 10.5 ± 1.2 | 10.8 ± 1.2 | 10.4 ± 1.2 | 0.034 |
RDW | 15.3 ± 2.1 | 15.2 ± 1.7 | 15.4 ± 2.2 | 0.598 |
NLR: neutrophil to lymphocyte ratio; MHR: monocyte to HDL-C ratio; RDW: red cell distribution width